Lipomics Technologies has announced that Scott Van Buskirk has joined the company in the newly created position of director of finance and operations
"Scott Van Buskirk brings 30 years of experience in growing early stage companies in the medical device and diagnostics industry," said Steve Watkins, Lipomics's president and chief scientific officer.
"He was part of the senior management team at EndoTherapeutics and UroSystems, both successfully divested to major medical device companies.
"He has extensive consulting experience in operations, finance and marketing, supporting emerging companies from seed stage through market introduction.
"Scott will add practical business perspective and a range of skills that will be invaluable to us as we convert our technologies into commercially available diagnostics".
"I am excited to be part of an enterprise with such a broad range of opportunities," said Scott Van Buskirk, director of finance and operations at Lipomics.
"The science here is solid and I look forward to being a part of this team".
Van Buskirk holds an undergraduate degree in political science and an MBA from the St Mary's College executive MBA programme.
